POET Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage Compass Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Pipeline Progress AWK Q1 2026 Earnings EPS Falls Short Shares Slip Slightly INBS Q1 2025 Earnings EPS Misses Estimates as Company Reports No Revenue OII Q1 2026 Earnings EPS Beats Estimates by 116 Stock Edges Higher STUB Q1 2026 Earnings Strong EPS Beat Amidst Operational Focus